Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
53.8%
% of BBH's 28 holdings also in BBP
23.0%
% of BBP's 65 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 3.4% | 2.1% | 2.1% |
|
GILEAD SCIENCES INC | 7.8% | 1.8% | 1.8% |
|
SAREPTA THERAPEUTICS INC | 2.4% | 1.7% | 1.7% |
|
AMGEN INC | 15.4% | 1.6% | 1.6% |
|
NEUROCRINE BIOSCIENCES INC | 2.5% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to BBP
|
AMGEN INC | 13.8% |
|
VERTEX PHARMACEUTICALS INC | 8.3% |
|
REGENERON PHARMACEUTICALS | 7.2% |
|
GILEAD SCIENCES INC | 6.0% |
 |
ARGENX SE ADR | 5.7% |
|
IQVIA HOLDINGS INC | 5.4% |
|
ILLUMINA INC | 4.2% |
 |
ICON PLC | 4.2% |
|
NATERA INC | 2.7% |
|
BEIGENE LTD. SPONSORED ADR | 2.5% |
BBH Underweight Relative to BBP
|
MIRUM PHARMACEUTICALS, INC. | -2.4% |
|
TRAVERE THERAPEUTICS, INC. | -2.0% |
|
LIGAND PHARMACEUTICALS-CL B | -1.9% |
|
LEXICON PHARMACEUTICALS, INC. | -1.9% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -1.9% |
|
ACADIA PHARMACEUTICALS INC | -1.9% |
|
BIOCRYST PHARMACEUTICALS INC | -1.8% |
|
IONIS PHARMACEUTICALS, INC. | -1.8% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | -1.8% |
|
TG THERAPEUTICS INC | -1.8% |